Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03271021 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
A Phase 3 study, sponsored by Vyne Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,488
- Enrollment target
NCT03271021: Completed Phase 3 study, sponsored by Vyne Therapeutics.
NCT03271021 is a Phase 3 study that has completed, run by Vyne Therapeutics. The registered enrollment target is 1,488 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03271021, a Phase 3 study, has completed, sponsored by Vyne Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,488 participants
- Enrollment target
Study Summary
A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris (Study FX2017-22)
Primary Outcome
A decrease in the inflammatory lesion count from Baseline to Week 12.
Interventions
- DRUG Vehicle Foam
- DRUG FMX101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,488 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2018-09-04 |
| Phase | Phase 3 |
What the finished NCT03271021 record still lists
NCT03271021 is an interventional study that assigns participants to a tested intervention. Its 1,488 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% higher).
The record links to 0 conditions, and to 2 interventions - of which Vehicle Foam is the first listed.
NCT03271021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03271021 about?
NCT03271021 is a clinical study titled "A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris". A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris (Study FX2017-22)
What is the current status of trial NCT03271021?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,488 participants. The study started on 2017-07-17. Estimated completion is 2018-09-04.
What interventions are being tested in trial NCT03271021?
The interventions under investigation include: Vehicle Foam (DRUG), FMX101 (DRUG).
Who is sponsoring clinical trial NCT03271021?
This trial is sponsored by Vyne Therapeutics, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03271021's enrollment target sits among peer trials
1,488 163rd of 2000 higher than 1,838 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI